Kiro
Alexandre Guenoun has a diverse range of work experience. Alexandre is the Founder and CEO of Kiro, a position they have held since 2019. Prior to that, they worked as a Strategy Consultant at Oliver Wyman from 2016 to 2017. Alexandre also served as a Private Equity Analyst (LVMH Group) at L Catterton from 2014 to 2015. Alexandre was the President of ESSEC Transaction from 2013 to 2014, and they were a Finance & Strategy analyst at Ahilya Ltd in 2013. Alexandre began their professional career as an Analyst intern at Mediaperformances in 2012.
Alexandre Guenoun has a Master's degree in Management from ESSEC Business School, with a double major in Corporate Strategy and Strategic Business Analytics. Alexandre also attended IPESUP for Preparatory Classes in the Scientific Section. In addition, Alexandre attended the University of California, Berkeley for a year, studying at the Berkeley School of Engineering and Berkeley School of Law. Alexandre also spent some time at Università Bocconi studying Management. Alexandre has obtained certifications in Data Analysis for Life Sciences: Statistics and R (by Harvard University) and in R Language from DataCamp.
This person is not in any teams
Kiro
Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical experts to build together a new approach to medical biology that is more understandable, personalized and relevant for the sake of patients.